$CEOS “Penny Stock 101” Promoter Rank: 22/25 CeCors, Inc. Newsletter 11:05:20 AM July 26, 2022

on July 26, 2022 Newsletters and Tags: , , , , , , , , , , with 0 comments

Overall Perfomance for "Penny Stock 101"

The following three charts can be used by potential investors to gauge the performance of "Penny Stock 101":


25 out of 58 campaigns closed down on first day


30 out of 58 campaigns closed up on first day


3 out of 58 campaigns had no net effect

CEOS Promotional Newsletter

The following is a newsletter released by "Penny Stock 101" promoting CeCors, Inc.


The following newsletter has not been verified for accuracy or completeness.

Alert Price $0.06


Turn your full attention to

The exciting company just released a yesterday that could ignite a bullish rally for this low-float, 6-cent Mushroom play

About the Company

PsyKey, Inc. specializes in the development and commercialization of mycology based entheogenic, adaptogenic, and nootropic ingredients and formulations. From functional to psychedelic PsyKey believes in the magic of mushrooms.

As part of our optimal wellness strategy, PsyKey understands the importance of access to support services and healthcare professionals, and is engaged in the development of tools that will aid in removing barriers and providing inclusivity.

The companys retail products will include Functional Mushroom coffees and teas, oral supplements, and single serve drink mixes. All products are developed with premium quality ingredients and are designed to provide the best possible results for consumers.

Our formulations are created utilizing functional mushrooms that have been used in traditional Eastern medicine and holistic healing for hundreds of years. These mushrooms include Reishi, Chaga, Lions Mane, Turkey Tail, Cordyceps, and Shiitake mushrooms. All products are manufactured in North American based GMP site licensed facilities.

Shareholders and interested parties are encouraged to follow for all Company updates.

Why Mushrooms

Chaga Mushroom History Chaga mushrooms, also known by their scientific name Inonotus obliquus, typically grow on birch tree bark in cold climates across the globe. Youll find them in Russia, Northern Europe, Korea, Canada, and even in Alaska in the United States.

What Are The Benefits Of Lions Mane Mushrooms The lions mane mushroom has a distinctive appearance and an even more distinctive reputation in functional medicine. It has the potential to help improve a wide variety of health issues, including anxiety and depression, inflammation, diabetes, and even cancer.

What Are The Benefits Of Maitake Mushrooms Maitake mushrooms are a highly effective form of functional medicine, as well as a delicious ingredient for mushroom coffee. Theyre extremely popular, both for eating and for their health benefits.

What Are The Benefits Of Reishi Ganoderma Mushrooms The reishi ganoderma mushroom is an incredible fungus to add to your functional coffee, as it boosts your immune system and fights cancer. It also comes with other health benefits and few reported side effects, which is likely the reason practitioners of Eastern medicine have used it for over 2000 years.

What Are The Benefits Of Turkey Tail Turkey Tail Turkey tail mushrooms are beautiful, multi-colored fungi that are well known to lovers of functional medicine and functional coffee. Their popularity is due to their powerful health benefits, which may include fighting cancer and reducing the negative side effects of chemotherapy.

What Are The Benefits Of Cordyceps Mushrooms Ever heard of the Cordyceps mushroom If not, youve come to the right place The cordyceps mushroom is a type of functional mushroom that is used as a popular performance enhancement ingredient. As such, you will often find that functional mushrooms are promoted in diets for men and women who want to improve their workouts.

CARSON CITY, NV ACCESSWIRE July 25, 2022 CECORS, INC. OTC PINKCEOS CeCors, PsyKey or the Company, through its wholly-owned subsidiary PsyKey Inc. proudly announces the initial segment fulfillment of the $50,000 purchase order of its functional mushroom-infused coffee line from innovative marketing firm Union Marketing.

The initial fulfillment is the first of two segments. It includes the delivery of 900 boxes of PsyKey's four functional mushroom-infused coffee pods and educational, marketing, and branding material.

The milestone of fulfilling the first segment of this purchase order with Union Marketing is both exciting and an important foundational step for the company. We look forward to a long and mutually beneficial partnership. Distribution is paramount when aggressively scaling a brand. Being strategically partnered with a company whose targeted network consists of over 750,000 engaged members will give us a competitive advantage over others in the functional beverage industry.

Our first target is to obtain just 1%-member engagement on a monthly subscription program. That equals 7,500 new customers with the potential of nearly $250,000 in monthly revenue. We are confident that the benefits and great flavor of our products, combined with Union Marketing's expertise in subscription-based advertising, will allow us to win over many new and repeat customers. This is the very first stage of growing our distribution, sales, and brand awareness, following the successful launch of our new website and Direct-to-Consumer E-Commerce platform. Said Amar Bhatal, President of PsyKey Inc.

Not only have we taken tremendous steps to develop multiple functional products, from securing some of the highest quality raw ingredients to strategically partnering with various industry experts, but we have always believed that taste is king. Based on our initial customer feedback, we are confident the team has delivered on its initial promises. In addition, our seasoned sales team is urgently pursuing numerous other distribution channels in Canada and the US. We look forward to updating our valued shareholders in the very near future on all developments. Continued Amar Bhatal, President of PsyKey Inc.

Union Marketing

Union Marketing is a creative marketing firm focused on BRINGING INNOVATION TO UNIONS. We assist unions and associations alike in building successful promotional campaigns and modernizing their communications through innovative products and services.

Unionized since 2013, our staff have a unique understanding of union culture and issues surrounding the labor movement. Through this understanding, we are able to provide clients with the services that are most effective in cultivating a thriving membership.

Yesterday's news was exactly the follow up that we were looking for from the company after their initial series of announcements earlier in the year.

CARSON CITY, NV ACCESSWIRE June 14, 2022 CECORS, INC. OTC PINKCEOS CeCors, PsyKey or the Company is excited to announce it has completed the final production of its premium functional mushroom-infused coffee line and will launch its highly anticipated products in tandem with its new website and integrated e-commerce platform. The launch of the website will occur on Monday, June 20th, 2022.

According to a report published by Allied Market Research, the global functional mushroom market generated $7.98 billion in 2020 and is estimated to reach $19.33 billion by 2030, witnessing a CAGR of 9.3% from 2021 to 2030.

PsyKey has been working to establish four functional mushroom-infused coffees, which have been curated by combining 100% fair trade organic Arabica coffee beans with the full dried and ground fruiting body of adaptogenic, immune-boosting functional mushrooms that are both nutrient and antioxidant-rich. These mushroom varieties include Lions Mane, Turkey Tail, Chaga, Reishi, Cordyceps, and Maitake. The development of proprietary formulations and sourcing of premium quality bulk mushrooms for our products has been completed in partnership with MycoVita and renowned mycologist Dr. Omon Isikhuemhen. The four functional formulations that have been developed include, MIND MEMORY, IMMUNE DEFEND, CALM RELAXED, AND REISHI GANO GOOD. Each functional coffee will be available to consumers in convenient single-serve coffee pods.

In conjunction with the completion of production, the Company will launch its new evolutionary website and direct-to-consumer e-commerce platform. During the development and production stages, the Company identified and engaged numerous distribution channels and potential key partnerships to support sales and build brand awareness. Initial product offerings will be available via the Company's e-commerce website, with additional distribution announcements soon to come.

This has been an incredible journey from concept to commercialization. We can stand behind the quality and functionality of our first product offering with our premium single-serve coffees, which is the first in our brand portfolio, stated president Mr. Amar Bhatal. We have taken our time to make sure that this coffee not only works, functionally but provides an incredible taste, something that stands out in the market. This is the first set of offerings in the portfolio - we have been developing other, various unique delivery systems for our proprietary formulations that we would look forward to offering to our consumers. A very exciting time to be a PsyKey shareholder, Continued Mr. Bhatal.

CARSON CITY, NV ACCESSWIRE March 7, 2022 CECORS, INC. OTC PINKCEOS CeCors, PsyKey or the Company. is pleased to announce that through a non-dilutive restricted stock transaction, the company has acquired 100 percent of Nutra-Rox LLC, specializing in products featuring functional carbonated crystal delivery technology Think Pop Rocks like candy. Nutra-Rox formulates and manufactures innovative consumer products utilizing this patent-pending delivery technology for nutraceuticals and bioactive ingredients. Under the terms of the acquisition agreement, Nutra-Rox shareholders will be subject to a 2-year regulatory hold.

Nutra-Rox delivery technology allows for bioavailable ingredients such as functional mushrooms delivered via carbonated crystals, that create a multi-sensory sensation in the mouth which provides an unmatched user experience. With the massive popularity of enjoyable to use delivery systems such as gummy and candy supplements and vitamins, this novel technology provides the company a unique delivery system in the fast-evolving functional mushroom and innovative wellness markets. The Nutra-Rox acquisition will help increase shareholder value by providing the company expanded novel product offerings, sales, and distribution.

The Nutra-Rox management team has over 50 years of collective experience in research, product development, manufacturing, branding, marketing, sales and distribution. Nutra-Rox is also the parent company of Breath Rox, a sugar free popping fresh breath treatment which delivers zinc gluconate to help reduce odor causing bacteria in the mouth. Breath Rox has been sold on HSN Home Shopping Network, online, and continues to pursue additional distribution opportunities including retail and international markets.

We're excited and eagerly looking forward to the future with this acquisition said Amar Bhatal president of PsyKey, We feel the Nutra-Rox teams' diverse expertise and innovative product development capabilities, will serve as a powerful catalyst in helping PsyKey achieve its goals of increasing shareholder value, while becoming a standout innovative wellness company.

Nutra-Rox CIO David Anderson who has managed the company's efforts over the last two years on HSN stated, We've witnessed the excitement consumers express when using a popping crystal product, as it's fun, different and most importantly, effective. Mr. Anderson continued, Having worked with our visionary executives for over 20 years, I can see this new venture allowing the company to achieve tremendous success. Our team is currently working on several new formulas which will be released in the coming weeks.

CEOS' involvement in this up coming industry Mushroom industry is incredibly exciting...

We are expecting larger product placement orders from the company in the near future.

The possibilities of upwards action are absolutely endless for this tiny-float, 6-cent Mushroom play...

A run to just 12-cents per share would net almost 100% in profits...

A run to just 18-cents per share would net almost 200% in profits...

A run to just 24-cents per share would net almost 300% in profits...

Make sure you don't delay pull up CEOS on your trading screen right away

Best Regards,

The PennyStock101 Team


Please read our Full Disclaimer

This newsletter is a Paid Advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC, the Financial Marketing Group LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to I or we or our refers to MJ Capital, LLC , the Financial Marketing Group LLC, and PennyStockLocks, LLC.

You are reading this newsletter because you have subscribed via our opt-In signup form on our website. If you have been subscribed by accident, then you may .

By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editors, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.

We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here We do NOT own any shares of the companies mentioned herewithin, nor intend to buy any in the future.

You should read and review, if and to the extent available, any information concerning an advertised company available at the web sites of the U.S. Securities and Exchange Commission the SEC at and the Financial Industry Regulatory Authority the FINRA at We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud at , as well as related information published by the NASD on how to invest carefully. You are responsible for verifying all claims and conducting your own due diligence. You agree and acknowledge that any hyperlinks to the website of 1 an advertised company, 2 the party issuing or preparing the information for the advertised company, or 3 other information contained in our disseminated emails is provided only for your reference and convenience. We are not responsible for the accuracy or reliability of these external sites, nor are we responsible for the content, advertising, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated email or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on us, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink. You also acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser. You acknowledge that you will consult with your own advisers regarding any decisions as to any advertised company.

Our business model is to receive financial compensation to promote public companies. In accordance with Section 17b of the Securities Act of 1933, you are hereby advised that we are being paid on a Cost-Per-Click basis which may exceed a fee of over $1000.00 in cash, from a third party as compensation for the distribution of this advertisement.

We have been compensated up to ten thousand dollars electronically by ACN LLC to conduct a two-day 726-2722 investor relations advertising marketing campaign for CEOS.

Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.

We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled companys website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, we often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writers communications regarding the profiled companys. You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.

Will everyone receive the Information at the same time
No. The Information may be sent to potential investors at different times that are minutes, hours, days or even weeks apart.

How is a potential investor impacted if they receive the Information later than other investors
If the trading volume and price of a Profile Issuers securities increases after the Information is provided to an earlier group of investors, then subsequent investors will pay inflated prices for any securities of the Profiled Issuers that they purchase. This will likely result in the Profiled Issuers having trading losses.

Last 2 Stock Promotions By "Penny Stock 101"

Symbol Company Start Date Close Change
ATHC Accelerated Technologies Holding Corp. July 10, 2022 0.274 -22%
HIRU Hiru Corp. May 18, 2022 0.0033 10%